• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    All News #Library
    Biotech

    Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3

    FIERCE BIOTECH

    After FDA rejection, Regeneron scores EU nod for Lynozyfic

    FIERCE PHARMA

    Biohaven lands funding Oberland funding deal worth up to $600M

    FIERCE BIOTEC

    Merck KGaA in $3.9 B deal to buy US biotech firm SpringWorks

    REUTERS

    Dr Reddy`s to introduce Sanofi`s novel drug in India

    PRESS RELEASE

    Ferrer collaboration with Prilenia for Pridopidine deal

    BUSINESSWIRE

    US FDA requests Novavax for new COVID-19 trial

    REUTERS

    Pfizer`s Sasanlimab Combo Improves Survival in Bladder Cancer

    BUSINESSWIRE

    J&J’s TAR-200 monotherapy achieves 80% disease-free survival

    GLOBENEWSIRE

    Relmada Therapeutics To Present NDV-01 Data at AUA2025

    GLOBENEWSWIRE

    Abpro, Celltrion reveal data for ABP-102/CT-P72 at AACR 2025

    GLOBENEWSWIRE

    Precede Shows Blood Test Resolves Tumor Gene Expression

    GLOBENEWSWIRE

    Y-mAbs Presents CD38-SADA Pharmacokinetics at 2025 AACR Meeting

    GLOBENEWSWIRE

    Keytruda improves survival in head and neck Cancer

    BUSINESSWIRE

    OPTIMA II: UGN-102 Shows Two-Year Median Response

    BUSINESSWIRE

    UGN-102 Trials Show No QoL Impact in LG-IR-NMIBC Patients

    BUSINESSWIRE

    OLYMPUS Study: 4-Year Response With JELMYTO

    BUSINESSWIRE

    Nona Biosciences` Partner Pfizer Presents Data on TOP1i-Based ADC

    PR NEWSWIRE

    Innovent Presents Preclinical Data of Multiple Novel Molecules

    PR NEWSWIRE

    ImmVira Presents Clinical Result of MVR-C5252 at 2025 AACR Meeting

    PR NEWSWIRE

    Abbisko`s Pre-clinical Results on ABSK112 , ABSK131, ABK-KRAS-1

    PR NEWSWIRE

    J&J puts ImmunityBio on defense mode in bladder cancer

    FIERCE PHARMA

    Levicept Presents Positive Phase II Data for LEVI-04

    GLOBENEWSWIRE

    GenVivo Highlights GEN-1013 at 2025 AACR Annual Meeting

    GLOBENEWSWIRE

    Valneva Update on French Authorities` Chikungunya Vaccine

    GLOBENEWSWIRE

    IO Biotech Highlights Cancer Vaccines at AACR Annual Meeting 2025

    GLOBENEWSWIRE

    CG Oncology Announces Durability Data in BOND-003 at AUA

    GLOBENEWSWIRE

    UroGen Pharma Reports Positive Phase 1 Results for UGN-301

    BUSINESSWIRE

    UroGen reports 80.6% 18-Month Response Rate in UGN-102 Trial

    BUSINESSWIRE

    ONO PHARMA USA Announces 2025 Golden Ticket Competition

    PR NEWSWIRE

    Caribou cuts 32% of staff, purges cell therapy pipeline

    FIERCE BIOTECH

    Vyne’s psoriasis drug hit with FDA hold over testicular toxicity

    FIERCE BIOTECH

    Formosa Pharma & Saval Corporation License Clobetasol Propionate

    PR NEWSWIRE

    Cantargia shows Nadunolimab reduces CIPN at AACR

    ACCESSWIRE

    Cantargia Presents Preclinical Results on Anti-IL1RAP ADC at Canc

    ACCESSWIRE

    ALX Oncology doubles down as lead asset fails 2 phase 2 trials

    FIERCE BIOTECH

    Summit stock drops on Akeso bispecific OS data vs. Keytruda

    FIERCE PHARMA

    Lilly requests EMA to re-examine Alzheimer`s drug recommendation

    REUTERS

    Sensorion Announces Pr. Natalie Loundon at 2025 ASPO Meeting

    BUSINESSWIRE

    Iksuda to Present Growing ADC Pipeline at AACR

    BUSINESSWIRE

    ClearB Therapeutics to Present Pre-Clinical Hepatitis B Data

    BUSINESSWIRE

    BioSkryb Genomics and Tecan launch single-cell multiomics workflow

    BUSINESSWIRE

    Nucleix to Present Bladder EpiCheck® Data at AUA 2025

    BUSINESSWIRE

    Radiant Biotherapeutics Poster Presentation at 2025 AACR Meeting

    BUSINESSWIRE

    Onchilles Pharma Presents New Data at AACR 2025 on N17350

    BUSINESSWIRE

    Talus Bio Presents Transcription Factor Data at AACR Meeting 2025

    BUSINESSWIRE

    CatalYm to Present Data on GDF-15 Blockade at AACR 2025

    BUSINESSWIRE

    Repare Therapeutics: Six Abstracts Accepted at AACR 2025

    BUSINESSWIRE

    Nimbus Therapeutics Starts First-in-Human Trial with NDI-219216

    BUSINESSWIRE

    NextPoint Therapeutics to Present Preclinical Data on NPX125

    BUSINESSWIRE

    Obsidian Therapeutics Presents at AACR Annual Meeting

    BUSINESSWIRE

    FORE Biotherapeutics Presents Plixorafenib Results at AACR 2025

    BUSINESSWIRE

    Agenus presents BOT/BAL Data in Liver Cancer at AACR 2025

    BUSINESSWIRE

    Zai Lab Presents Data on Next-Gen Oncology Therapies at AACR 2025

    BUSINESSWIRE

    Longhorn Shows LHNVD-303 Sepsis Vaccine Data at WVC

    BUSINESSWIRE

    Tremfya approved by European Commission for ulcerative colitis

    GLOBENEWSWIRE

    Y-mAbs Starts Phase 1 Trial for CD38-SADA Radioimmunotherapy

    GLOBENEWSWIRE

    Polyrizon Reports Successful Safety Study of PL-14 Allergy Blocker

    GLOBENEWSWIRE

    Junshi Biosciences announces sNDA approval of Toripalimab for 1st

    GLOBENEWSWIRE

    Clearmind Files Patent for Novel Eating Disorder Treatment

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.